|
Match
|
Document |
Document Title |
|
|
US20120101427 |
NOVEL PHOTOSENSITIZER FORMULATIONS FOR ORAL ADMINISTRATION
The present invention provides novel drug formulations for oral administration for diverse medical applications including anticancer, antimetastatic, antibacterial, antifungal, antiprotozoic,... |
|
|
US20130149277 |
PTEROSTILBENE AND PVP GRAPE JUICE EXTRACT COMBINATION FOR TREATMENT OF METABOLIC, VASCULAR, AND NEURODEGENERATIVE DISORDERS
A pharmaceutical composition is provided comprising a therapeutically effective amount of pterostilbene, a therapeutically effective amount of a polyphenolic-PVP extract of grape juice, and a... |
|
|
US20110142789 |
Compositions and Methods for the Diagnosis and Treatment of Amyotrophic Lateral Sclerosis
Compositions and methods for diagnosis and treatment of ALS are provided. |
|
|
US20130189219 |
N-TERMINALLY CHEMICALLY MODIFIED PROTEIN COMPOSITIONS AND METHODS
Provided herein are methods and compositions relating to the attachment of water soluble polymers to proteins. Provided are novel methods for N-terminally modifying proteins or analogs thereof,... |
|
|
US20120027814 |
Polymeric Fibers Having Tissue Reactive Members
A method for bonding a polymeric fiber to tissue is provided which includes providing a polymeric fiber having a plurality of tissue reactive members linked to a surface of the fiber via a... |
|
|
US20130064786 |
siRNA HYDROGEL AND METHOD FOR MANUFACTURING THE SAME
The present invention relates to siRNA hydrogel and a method for manufacturing the same, and more particularly, to siRNA hydrogel for targeted gene silencing, which is nano-structured for targeted... |
|
|
US20110200655 |
Systems and methods that kill infectious agents (bacteria) without the use of a systemic anti-biotic
A medical product is provided that is selected from at least one of, nasal cannulas, oxygen masks, wound dressings, bandages, band aids, catheters, endotrachial tubes, condoms, surgical and other... |
|
|
US20130115165 |
Water-Dispersible Oral, Parenteral, and Topical Formulations for Poorly Water Soluble Drugs Using Smart Polymeric
Polymeric nanoparticles with a hydrophobic core and a hydrophilic shell are formed from: 1) N-isopropylacrylamide (NIPAAM), at a molar ratio of about 50% to about 90%, and preferably 60% for... |
|
|
US20110159062 |
ANTISEPTIC COMPOSITIONS AND USES THEREOF
Antiseptic compositions and kits containing a source of silver ions and menthol, which act in synergy such that a concentration of silver ions in the composition is substantially reduced, are... |
|
|
US20100015083 |
Method of producing pvp/fullerene complex and aqueous solution thereof
An aromatic hydrocarbon solution of a fullerene or a fullerene mixture is mixed with an ethanol solution of polyvinylpyrrolidone (PVP), water is added to the mixed solution, the solvent is removed... |
|
|
US20110250149 |
Tiotropium Bromide Having a Low Degree of Crystallinity
The present invention provides tiotropium bromide having a low degree of crystallinity. The present invention also provides a complex of tiotropium bromide and polyvinylpyrrolidone, processes for... |
|
|
US20120301530 |
COMPOSITIONS AND METHODS FOR ANTIMICROBIAL METAL NANOPARTICLES
Embodiments of the invention are directed to a composition having antimicrobial activity comprising particles comprising at least one inorganic copper salt; and at least one functionalizing agent... |
|
|
US20080072640 |
Insecticidal Fertilizer Solids and Method of Preparation
An insecticidal fertilizer composition is prepared by contacting a solid fertilizer with a solution of a nicotinyl insecticide. The nicotinyl insecticide solution can be imidacloprid in a solvent,... |
|
|
US20110165114 |
DRUG DELIVERY COMPOSITION
There is provided a non-water soluble drug delivery composition comprising a conjugate and a polymer matrix wherein exposure of the composition to electromagnetic radiation at a suitable... |
|
|
US20120052042 |
AMPHIPHILIC COMPOUNDS AND SELF-ASSEMBLING COMPOSITIONS MADE THEREFROM
The present disclosure relates to amphiphilic compounds, self assembling compositions formed from the amphiphilic compounds and methods of making such compositions. |
|
|
US20110020422 |
Hydroxyapatite-Targeting Poly(ethylene glycol) and Related Polymers
Isolatable, hydroxyapatite-targeting polymeric structures, and biologically active conjugates thereof, are provided. The polymeric structure includes a linear or branched water-soluble and... |
|
|
US20110135571 |
HYBRID NANOPARTICLES AS ANTI-CANCER THERAPEUTIC AGENTS AND DUAL THERAPEUTIC/IMAGING CONTRAST AGENTS
The presently disclosed subject matter provides nanoscale coordination polymers for use as anticancer agents and as dual anticancer/imaging agents. The nanoscale coordination polymers can comprise... |
|
|
US20140046279 |
Method for preventing the crystallisation of pharmaceuticals in a polymer film
The invention relates to a method for preventing the crystallization of a pharmaceutical in a polymer film, wherein the solvent-containing coating compound, which comprises a matrix-forming... |
|
|
US20150166706 |
NITRIC OXIDE-RELEASING DIAZENIUMDIOLATED POLYVINYLPYRROLIDONE-BASED POLYMERS, AND COMPOSITIONS, MEDICAL DEVICES, AND USES THEREOF
Disclosed is a nitric oxide-releasing polyvinylpyrrolidone-based polymer derived from N-vinylpyrrolidone monomer and at least one nitric oxide releasing N2O2− group, in which the N2O2− group is... |
|
|
US20150037275 |
RIFAXIMIN COMPLEXES
There is provided a complex comprising rifaximin and a complexing agent, wherein the complexing agent is a polyvinyl pyrrolidone (PVP) or a cyclodextrin. There is also provided a process for... |
|
|
US20110262378 |
Rifaximin Complexes
There is provided a complex comprising rifaximin and a complexing agent, wherein the complexing agent is a polyvinyl pyrrolidone (PVP) or a cyclodextrin. There is also provided a process for... |
|
|
US20120195847 |
POLYMER CONJUGATES OF BIPHALIN PEPTIDES
The invention provides peptides that are chemically modified by covalent attachment of a water soluble oligomer. A conjugate of the invention, when administered by any of a number of... |
|
|
US20130160761 |
Pharmaceutical Aerosol Composition
A pharmaceutical aerosol composition comprising at least one hydrofluoroalkane propellant; at least one active agent complexed with an adjuvant; and, optionally, at least one pharmaceutically... |